Home / Featured Companies / Amgen Historical Data

Amgen (AMGN) Financials

Amgen (AMGN) Historical Financial Statements and Key Metrics for 1989 - 2020

Full Amgen financials for 1989 - 2020 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Amgen Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2020-Dec-31 6,634 5,037 (75.9 %) 2,008 (30.3 %) 1,615 (24.3 %) 2,881 2.76
2020-Sep-30 6,423 4,862 (75.7 %) 2,453 (34.3 %) 2,021 (31.5 %) 3,409 3.43
2020-Jun-30 6,206 4,718 (76.0 %) 2,323 (37.4 %) 1,803 (29.1 %) 2,667 3.05
2020-Mar-31 6,161 4,648 (75.4 %) 2,355 (38.2 %) 1,825 (29.6 %) 2,582 3.07
2019-Dec-31 6,197 4,944 (79.8 %) 2,048 (33.0 %) 1,703 (27.5 %) 2,620 2.85
2019-Sep-30 5,737 4,701 (81.9 %) 2,476 (43.2 %) 1,968 (34.3 %) 2,586 3.27
2019-Jun-30 5,871 4,859 (82.8 %) 2,678 (45.6 %) 2,179 (37.1 %) 2,951 3.57
Full historical income statements for 1989 - 2020 is included in the US Historical Financials dataset.

Amgen Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2020-Dec-31 62,948 53,539 32,986 9,409 10,647
2020-Sep-30 64,637 53,678 34,287 10,959 12,360
2020-Jun-30 65,011 54,352 34,224 10,659 11,421
2020-Mar-31 61,669 52,184 31,848 9,485 8,012
2019-Dec-31 59,707 50,034 29,903 9,673 8,911
2019-Sep-30 59,535 48,608 29,791 10,927 20,853
2019-Jun-30 59,373 48,579 30,614 10,794 21,758
Full historical balance sheet data for 1989 - 2020 is included in the US Historical Financials dataset.

Amgen Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2020-Dec-31 2,153 -1,384 -3,590 1,980
2020-Sep-30 3,368 0 0 3,233
2020-Jun-30 2,842 -2,159 775 2,684
2020-Mar-31 2,134 -230 -254 1,992
2019-Dec-31 2,514 -5,963 -1,929 2,326
2019-Sep-30 3,377 5,372 -2,859 3,207
2019-Jun-30 1,414 2,745 -5,992 1,270
Full historical cash flow data for 1989 - 2020 is included in the US Historical Financials dataset.

Amgen Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2020-Dec-31 134,503 161,223 20.27 20.82 14.30
2020-Sep-30 148,684 177,066 23.15 73.57 13.57
2020-Jun-30 138,700 163,688 22.35 76.93 13.01
2020-Mar-31 118,816 141,137 19.29 65.10 12.53
2019-Dec-31 140,999 161,912 22.75 82.79 14.58
2019-Sep-30 113,376 129,703 19.76 57.61 10.38
2019-Jun-30 109,854 132,127 18.71 50.41 10.18
Full historical valuation and operating metrics for 1989 - 2020 are included in the US Historical Financials dataset.